Cargando…

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer

This phase II study assessed the clinical efficacy and tolerability of a combination of mitomycin C, vinblastine and cisplatin in patients with metastatic breast cancer (MBC) previously treated with chemotherapy. A total of 87 patients with MBC, most of whom had been exposed to anthracyclines (92%)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urruticoechea, A, Archer, C D, Assersohn, L A, Gregory, R K, Verrill, M, Mendes, R, Walsh, G, Smith, I E, Johnston, S R D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362079/ https://www.ncbi.nlm.nih.gov/pubmed/15685237 http://dx.doi.org/10.1038/sj.bjc.6602367

Ejemplares similares

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
por: Ellis, P. A., et al.
Publicado: (1995)

A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
por: Hickish, T. F., et al.
Publicado: (1998)

Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
por: Giaccone, G., et al.
Publicado: (1987)

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer.
por: Hardy, J. R., et al.
Publicado: (1989)

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy
por: Han, K S, et al.
Publicado: (2008)

Ogilvie Syndrome in a Refractory Germ Cell Tumor Treated with Vinblastine, Ifosfamide and Cisplatin Regimen
por: Varayathu, Hrishi, et al.
Publicado: (2020)

Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer
por: Arai, Satoko, et al.
Publicado: (2018)

Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer : A low cost effective regimen
por: Cascinu, S, et al.
Publicado: (2002)

Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers – a new active regimen
por: Slater, S, et al.
Publicado: (2002)

Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma
por: Ng, M, et al.
Publicado: (2005)

SQL Server MVP deep dives
por: Nielsen, Paul
Publicado: (2010)

SQL Server MVP deep dives.
por: Delaney, Kalen, et al.
Publicado: (2012)

A New Malignant MVP Phenotype?
por: Thamman, Ritu
Publicado: (2021)

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
por: Baldini, E., et al.
Publicado: (1998)

Regulation of initial vinblastine influx by P-glycoprotein.
por: Shalinsky, D. R., et al.
Publicado: (1993)

MVP and vaults: a role in the radiation response
por: Lara, Pedro C, et al.
Publicado: (2011)

MVP: a microbe–phage interaction database
por: Gao, Na L, et al.
Publicado: (2018)

Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma
por: Mulatero, C, et al.
Publicado: (2000)

Successful embolization of a congenital intra-hepatic arterioportal fistula in a neonate with the MVP Microvascular Plug system (MVP-3Q)
por: Gladkikh, Maria, et al.
Publicado: (2022)

THE EFFECTS OF VINBLASTINE ON ISOLATED XENOPUS OOCYTES
por: Dumont, James N., et al.
Publicado: (1972)

MVP predicts the pathogenicity of missense variants by deep learning
por: Qi, Hongjian, et al.
Publicado: (2021)

Biochemical and Structural Analysis of the Hyperpolarization-Activated K(+) Channel MVP
por: Randich, Amelia M., et al.
Publicado: (2014)

The cryo-EM structure of the SNX–BAR Mvp1 tetramer
por: Sun, Dapeng, et al.
Publicado: (2020)

Vinblastine in the treatment of Hodgkin's disease.
por: Jelliffe, A. M.
Publicado: (1969)

Inhibition of interferon secretion by vinblastine
por: Havell, EA, et al.
Publicado: (1975)

Vinblastine-induced Acral Hyperpigmentation
por: Chakraborti, Annesha, et al.
Publicado: (2020)

Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
por: Lee, Franklin C., et al.
Publicado: (2013)

Tolerability of a rapid‐escalation vinblastine‐prednisolone protocol in dogs with mast cell tumours
por: Serra Varela, Juan Carlos, et al.
Publicado: (2016)

The mechanism of vault opening from the high resolution structure of the N-terminal repeats of MVP
por: Querol-Audí, Jordi, et al.
Publicado: (2009)

Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
por: BATGİ, Hikmettullah, et al.
Publicado: (2021)

Excel insights: a microsoft MVP guide to the best parts of Excel
por: MVPs, 24 Excel
Publicado: (2020)

Vinblastine Sulphate in the Treatment of Malignant Disease
por: Bleehen, N. M., et al.
Publicado: (1965)

Modifications on the Basic Skeletons of Vinblastine and Vincristine
por: Keglevich, Péter, et al.
Publicado: (2012)

Vinblastine: Neutropenia and thrombocytopenia: case report
Publicado: (2021)

EFFECT OF COLCHICINE AND VINBLASTINE ON THE TOPOGRAPHICAL SEPARATION OF MEMBRANE FUNCTIONS
por: Ukena, Thomas E., et al.
Publicado: (1972)

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer
por: Yarchoan, Mark, et al.
Publicado: (2017)

Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysis
por: Karadimou, Alexandra, et al.
Publicado: (2010)

Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine
por: Del Coco, Laura, et al.
Publicado: (2020)

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.
por: Mead, G. M., et al.
Publicado: (1998)

Vinblastine, an anticancer drug, causes constipation and oxidative stress as well as others disruptions in intestinal tract in rat
por: Rtibi, Kaïs, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0vo1b7dh7p67ldb8erblh1inin